Paired box 2 promotes progression of endometrial cancer via regulating cell cycle pathway

Background: Human paired box 2 (PAX2) plays a key role in cell fate, early patterning and organogenesis. Methods: We investigated the function of PAX2 on the biological behavior of endometrial cancer in vitro and in vivo and to explore the regulation mechanism, stable knocking-down and over-expression PAX2 endometrial cancer cell lines were established. CCK-8 and transwell assays were applied to determine proliferation, invasion and migration ability. Cell cycle distribution was analyzed by flow cytometry. Affymetrix GeneChip® human Exon 1.0 ST arrays was used to screen the downstream target genes of PAX2. Results: PAX2 significantly enhanced proliferation and invasiveness. In addition, PAX2 influenced the expression of cyclin-dependent kinase 1(CDK1), which play pivotal roles in cell cycle pathway. When CDK1 was knocked down, and the cell proliferation promotion role of PAX2 was attenuated dramatically to a level comparable with the control groups. Conclusions: PAX2, though influencing the expression of CDK1, promotes the proliferation, enhances the mobility of endometrial cancer cells, thus exerts an important role in the carcinogenesis of endometrial cancer. PAX2 may be a potential therapeutic target for endometrial cancer.

[1]  G. Ning,et al.  Digital quantification of precursor frequency in the fallopian tube and its significance , 2012, Modern Pathology.

[2]  A. Krasinskas,et al.  Is PAX2 a Reliable Marker in Differentiating Diffuse Malignant Mesotheliomas of Peritoneum From Serous Carcinomas of Müllerian Origin? , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[3]  G. Ning,et al.  PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer , 2012, Modern Pathology.

[4]  S. Taşkın,et al.  Expression pattern of PAX2 in hyperplastic and malignant endometrium , 2012, Archives of Gynecology and Obstetrics.

[5]  C. Lacombe,et al.  PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype , 2011, Molecular Cancer.

[6]  M. Roh,et al.  Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions , 2011, Diagnostic cytopathology.

[7]  Jessica L. Davis,et al.  PAX2 Expression in Wilms Tumors and Other Childhood Neoplasms , 2011, The American journal of surgical pathology.

[8]  P. Cheng,et al.  RNA interference of pax2 inhibits growth of transplanted human endometrial cancer cells in nude mice , 2011, Chinese journal of cancer.

[9]  E-hu Liu,et al.  2ME and 2OHE2 exhibit growth inhibitory effects and cell cycle arrest at G2/M in RL95-2 human endometrial cancer cells through activation of p53 and Chk1 , 2011, Molecular and Cellular Biochemistry.

[10]  J. McKenney,et al.  The Utility of Pax-2 and Renal Cell Carcinoma Marker Immunohistochemistry in Distinguishing Papillary Renal Cell Carcinoma From Nonrenal Cell Neoplasms With Papillary Features , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[11]  G. Ning,et al.  Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube , 2010, The Journal of pathology.

[12]  D. Neuberg,et al.  Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. , 2010, Cancer research.

[13]  L. Truong,et al.  PAX-2 Expression in Non-neoplastic, Primary Neoplastic, and Metastatic Neoplastic Tissue: A Comprehensive Immunohistochemical Study , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[14]  S. Bose,et al.  PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. , 2009, Molecular immunology.

[15]  M. Barbacid,et al.  Cell cycle, CDKs and cancer: a changing paradigm , 2009, Nature Reviews Cancer.

[16]  M. Amin,et al.  Diagnostic Implications of Transcription Factor Pax 2 Protein and Transmembrane Enzyme Complex Carbonic Anhydrase IX Immunoreactivity in Adult Renal Epithelial Neoplasms , 2009, The American journal of surgical pathology.

[17]  P. Grundy,et al.  WNT5A is regulated by PAX2 and may be involved in blastemal predominant Wilms tumorigenesis. , 2008, Neoplasia.

[18]  Mirana Ramialison,et al.  Rapid identification of PAX2/5/8 direct downstream targets in the otic vesicle by combinatorial use of bioinformatics tools , 2008, Genome Biology.

[19]  M. Bouchard,et al.  A novel gene downstream of Pax2 is overexpressed in Wilms' tumors and encodes for a Calcineurin A binding protein , 2008 .

[20]  Pierre Dubus,et al.  Cdk1 is sufficient to drive the mammalian cell cycle , 2007, Nature.

[21]  A. Borczuk,et al.  Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin? , 2007, Modern Pathology.

[22]  Andre C. Eaddy,et al.  Inhibition of PAX2 expression results in alternate cell death pathways in prostate cancer cells differing in p53 status. , 2007, Cancer letters.

[23]  P. Ganly,et al.  Translocation (5;10)(q22;q24) in a case of acute lymphoblastic leukemia. , 2006, Cancer genetics and cytogenetics.

[24]  J. Carl Barrett,et al.  Prediction of Lymph Node Metastasis in Patients with Endometrioid Endometrial Cancer Using Expression Microarray , 2006, Clinical Cancer Research.

[25]  Luyang Sun,et al.  Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis , 2005, Nature.

[26]  P. Kaldis,et al.  Cdc2–cyclin E complexes regulate the G1/S phase transition , 2005, Nature Cell Biology.

[27]  P. Cassoni,et al.  Role of Pax2 in Apoptosis Resistance and Proinvasive Phenotype of Kaposi's Sarcoma Cells* , 2004, Journal of Biological Chemistry.

[28]  G. Dressler,et al.  The Secreted Frizzled Related Protein 2 (SFRP2) Gene Is a Target of the Pax2 Transcription Factor* , 2003, Journal of Biological Chemistry.

[29]  M. Eccles,et al.  Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival , 2003, Oncogene.

[30]  G. Dressler,et al.  Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. , 2001, Development.

[31]  H. Cunliffe,et al.  Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2 , 1997, Oncogene.

[32]  J. Pelletier,et al.  The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). , 1996, Oncogene.